Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
53 participants
OBSERVATIONAL
2013-02-04
2013-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Regular Exercise During Pregnancy
NCT00476567
Acute Maternal and Fetal Effects of Exercise in Pregnancy
NCT01383889
Physical Activity and Sedentary Lifestyle During Pregnancy: Feasibility and Impact Study on Sedentary Behavior
NCT05225376
The Impact of Mobile Application-guided Physical Exercise on Physiological Parameters in Healthy Pregnant Women
NCT06722989
Effect of Regular Exercise in Prevention of Excessive Weight Gain in Pregnancy
NCT00617149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In non-pregnant individuals regular physical activity is associated with a reduced inflammatory state. The overall objective of the study is to investigate the interaction of maternal physical activity and pregnancy induced low-grade inflammation in the mother and feto-placental unit, and to assess th resulting effects on prenatal and postnatal development.
Specific research objective will be to study effects of maternal physical activity on:
1. low grade Inflammation in the mother an feto-placental unit;
2. maternal and fetal lipid profiles, including High Density Lipoprotein (HDL) proteome;
3. fetal growth and infant body composition;
4. transcriptomic and epigenetic profile in the placenta;
5. biomarkers of nutritive status;
6. psychological assessment: cardiac awareness; assessment of arterial stiffness; stress-coping questionaire
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
pregnant women who are physically active (spend a minimum of 150min/week with moderate to vigorous physical activity)
No interventions assigned to this group
Inactive
pregnant women who are physically inactive (spend less than 150min/week with moderate to vigorous physical activity)
No interventions assigned to this group
risk for hypertensive disorders
pregnant women with a history of preeclampsia or positive history for metabolic conditions increasing the risk of hypertensive disorders in pregnancy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* giving informed consent
Exclusion Criteria
* gestational age \> 14 weeks of gestation
* 3 or more consecutive miscarriages
* increased risk to or above 1:200 after combined test (Minimum parameters: maternal age, fetal crown-rump length (CRL), nuchal translucency, nasal bone and maternal biochemistry)
* fetal anomalies associated with possible growth or genetic anomalies
* Smoking
* diagnosed with Diabetes type 1 or 2 (T1D, T2D)
* for groups 1 and 2: maternal metabolic risk factors (autoimmune conditions, increased risk for thromboembolic events needing anticoagulative therapy)
* for groups 1 and 2: pre-pregnancy hypertension
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bence Csapo, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 24-245 ex 11/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.